Brief: SAB Biotherapeutics Announces Executive Leadership Change
02/02/2024 13:45
Feb 2 (Reuters) - SAB Biotherapeutics Inc SABS.O :
* SAB BIOTHERAPEUTICS INC - SAMUEL J. REICH, CURRENTLY
EXECUTIVE
CHAIRMAN OF SAB, WILL EXPAND HIS ROLE TO INCLUDE THAT OF CHIEF
EXECUTIVE OFFICER OF SAB
* SAB BIOTHERAPEUTICS INC - EDDIE J. SULLIVAN, WILL CONTINUE
HIS
ROLE AS PRESIDENT, AND AS A MEMBER OF BOARD OF DIRECTORS
Source text for Eikon: ID:nGNX272nhW
Further company coverage: SABS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SAB Biotherapeutics
See all newsSAB Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
SAB Biotherapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Ferrari, Hawkeye 360, Micron Technology
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies
U.S. STOCKS ON THE MOVE-InspireMD, MiniMed, SoFi Technologies